CBSE practical examinations will begin on January 1. Here's a look at the most common mistakes made by Class 10 and 12 ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Rocket Lab is getting ready to take a bigger bite out of the space launch market. The company ...

This article first appeared on GuruFocus. Rocket Lab (NASDAQ:RKLB) climbed about 2% on Tuesday after the company said it secured nearly C$1 million in research and development funding from the ...

What To Know: Rocket Lab announced via X that the launch window for the mission has been updated to no earlier than Dec. 12 to allow time for additional checkouts. This follows previous delays caused ...

Rick is a Wall Street Journal best-selling author with over 20 years of experience trading stocks and options. The most authoritative publications, including Good Morning America, Washington Post, ...

The deadline to file a claim for money from the $177 million AT&T class action settlement is coming up. AT&T agreed to the settlement to resolve a lawsuit that accused it of failing to protect ...

Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...

MIAMI BEACH, Fla., Nov. 25, 2025 /PRNewswire/ -- Immorta Bio Inc., a scientific longevity company pioneering therapies focusing on Treating Diseases of Aging and Treating Aging as Disease™, today ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Boston biotechnology company ...

An illustration of a protein created by Accipiter Bio that has two active sites, shown in light and darker green, that can simultaneously bind two targets. (Accipiter Bio Image) A Seattle biotech ...